Journal
EXPERT OPINION ON DRUG DISCOVERY
Volume 6, Issue 2, Pages 109-127Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1517/17460441.2011.547189
Keywords
drug discovery; in vivo brain microdialysis; neurodegenerative diseases; neuropsychiatric disorders
Categories
Funding
- Northeastern Ohio Universities Colleges of Medicine and Pharmacy (NEOUCOM)
- Stark Community Foundation
- U.S. Public Health Service NIH [DA07427]
- NIH [R01 NS060662, R01 AA011877]
- Department of Veterans Affairs
- Novartis
Ask authors/readers for more resources
Areas covered: We present a brief overview of principles and procedures related to in vivo microdialysis and detail the use of this technique in the preclinical assessment of drugs designed for use in the treatment of chemical addiction, neurodegenerative diseases, and psychiatric disorders including attention deficit hyperactivity disorder and schizophrenia. This review offers insights into the utility and versatility of this technique in pursuing neuropharmacological investigations and its potential in rational drug discovery. Expert opinion: In vivo microdialysis is a versatile technique, routinely used in pharmacological investigations of drugs for neurological disorders. Notably, it has been a powerful tool to elucidate neurochemical profiles and mechanisms of action of several classes of drugs and their effects on neurotransmitter systems. The exploitation and development of this technique for drug discovery will enable investigational new drug candidates to be rapidly moved into clinical trials, thus providing new therapies so in demand for neurological diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available